Skip to content
ClinCalc Pro
Menu
Direct-Acting Vasodilator — Hypertensive Emergency / Chronic Hypertension

Hydralazine

Brand names: Apresoline

Hydralazine is a direct-acting arterial vasodilator antihypertensive, used in resistant or severe hypertension, hypertension in pregnancy, and in heart failure combined with a nitrate.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It relaxes arteriolar smooth muscle directly, reducing systemic vascular resistance and arterial blood pressure.

Prescribing in practice

  • Long-term or higher-dose use can cause a drug-induced lupus-like syndrome, which should prompt review and discontinuation.
  • Reflex tachycardia and fluid retention often require co-administration of a beta-blocker and a diuretic.
  • In heart failure it is combined with a nitrate, particularly where renin-angiotensin system inhibitors are unsuitable.

Monitoring

Monitor blood pressure and heart rate, and remain alert for features of a lupus-like syndrome such as arthralgia and rash.

Counselling the patient

  • This medicine lowers blood pressure by relaxing the blood vessels.
  • Report persistent joint pains, fever, rash or unusual tiredness.
  • Do not stop the medicine suddenly without advice.

Evidence & guidelines

The combination of hydralazine with isosorbide dinitrate improved outcomes in heart failure trials, including benefit demonstrated in self-identified Black patients in the A-HeFT trial.

Reference: NICE NG133 (Hypertension in Pregnancy); Magee et al. NEJM 2015; NICE NG136; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.